Turning hard science into premium health ventures.

We discover, build and scale evidence-backed consumer brands—under one roof.

Home Header Image
ETHOS

Driven by Evidence.
Delivering Real Impact.

Our principles guide every venture we launch.

Features Image

Evidence-First

Only ingredients and technologies supported by peer-reviewed research in high-imact journals.
Features Image

Premium by Design

Products designed for efficacy, not margins. quality never compromised
Features Image

Radical Transparency

Open science, clear sourcing, measurable outcomes.

Our Venture Portfolio

Project "Helix"

Science-first, premium supplement brand—powered by a precision-nutrition AI platform. Co-created with a global advisory panel of world-leading nutrition KOLs.

  • Clinically-dosed core formulations + smart micro-add-ons
  • AI engine matches each user’s data to ingredients in seconds
  • Launching Q1 2026

People Who Bridge Science & Business

Two founders combine 20 + years of nutrition science with world class commercial execution to turn evidence into premium health brands.

Dr Graeme Smith
PhD, R. Nutritionist

PhD Nutritional Biochemist,
Co-Founder

With two decades of leadership across personalised-nutrition R&D, product strategy and venture creation, Graeme is a science-driven executive who transforms breakthrough research into premium consumer offerings. His career spans NEOM, Swisse Wellness, Prenetics and H&H Group, where he launched data-guided supplement lines and opened new APAC markets, underpinned by a PhD in Nutritional Biochemistry and patents in macronutrient sensitivity and exercise genotyping. Passionate about evidence-led innovation and high-performance teams, Graeme blends rigorous scientific insight with commercial acumen—publishing in tier-one journals, advising start-ups to multinationals, and building cross-functional ecosystems that deliver measurable impact and sustainable growth.

Moses Ceraman
MBA, FCG, FGIA

Corporate & Strategy Lead,
Co-Founder

With over three decades of leadership experience across business strategy, innovation, portfolio management, consulting, and finance, Moses is a seasoned business executive committed to driving ambitious growth and transformational outcomes. His extensive FMCG background includes launching new brands, establishing operations in new markets, and leading global systems rollouts, with a career shaped by globally renowned organizations such as EY, Dilmah Teas, Mars Inc., and Swisse Wellness.Passionate about building innovation-led cultures and high-performing ecosystems, Moses brings a powerful blend of strategic agility, commercial acumen, and strong stakeholder engagement to consistently deliver impactful results and foster sustainable success.

World-Class Scientists,
World-Class Ventures

Our advisory team—authors of hundreds of papers in the world’s top journals—guides every venture with gold-standard evidence and global credibility.

Professor David Cameron- Smith

Scientific Advisor

Professor David Cameron-Smith is an international authority on human nutrition with 25 years’ experience spanning academia, clinical research and food-industry innovation. Former Science Director of New Zealand’s High-Value Nutrition programme and current Chair of Nutrition at the University of Auckland’s Liggins Institute, he leads landmark studies on diet-gene interactions, muscle metabolism and healthy ageing, advising governments and global FMCG on evidence-based product strategy.

Professor Catherine Stanton

Scientific Advisor

Professor Catherine Stanton is a leading microbiome and functional-foods scientist with more than 25 years at Teagasc Moorepark and an adjunct professorship at University College Cork. Author of 600+ papers and multiple patents, she bridges dairy science, probiotics and infant nutrition, guiding global companies on translating gut-microbiota discoveries into clinically validated consumer products.

Professor Andrew Pipingas

Scientific Advisor

Professor Andrew Pipingas is a cognitive neuroscientist renowned for translating nutritional biochemistry into measurable brain-health outcomes. With over two decades at Swinburne’s Centre for Human Psychopharmacology, he leads placebo-controlled trials on polyphenols, nutraceuticals and lifestyle interventions, guiding government and industry partners on evidence-based strategies that enhance cognition, mood and healthy brain ageing.

Professor Paul Ross

Corporate & Strategy Lead, Co-Founder

Professor Paul Ross is an internationally acclaimed microbiologist and Director of APC Microbiome Ireland. Over a 30-year career—spanning Teagasc and University College Cork—he has authored 600+ papers and secured >20 patents on bacteriocins, probiotics and phage therapy, helping global nutrition and pharma partners convert breakthrough microbiome science into validated immune- and metabolic-health solutions.